Quarterly Result30 Oct 2026, 06:53 pm
Corona Remedies Declares Unaudited Q2 FY27 Results
AI Summary
Corona Remedies Ltd announced its unaudited financial results for the second quarter and half year ended September 30, 2026. The Board of Directors approved these results along with the limited review reports issued by M/s. Walker Chandiok & Co LLP. The company also made these results available on its website. The Board meeting to approve these results commenced at 03:30 p.m. and concluded at 04:40 p.m. on October 30, 2026.
Key Highlights
- Unaudited financial results for Q2 and H1 FY27 declared.
- Limited review reports from statutory auditors included.
- Results approved by the Board of Directors.
- Information available on the company website.
- Standalone financial results reviewed.
Price Impact
More from CORONA